Old Web
English
Sign In
Acemap
>
authorDetail
>
Leo Lai Hok Kan
Leo Lai Hok Kan
University of Hong Kong
Medicine
Cancer research
Myeloid leukemia
Follistatin
Biomarker (medicine)
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Investigating the role of TP53 in acute myeloid leukaemia (AML) using the zebrafish model
2020
Leo Lai Hok Kan
jianlihe
Show All
Source
Cite
Save
Citations (0)
Corrigendum to: Follistatin is a novel therapeutic target and biomarker in FLT 3/ ITD acute myeloid leukemia (EMBO Molecular Medicine, (2020), 12, 4, 10.15252/emmm.201910895)
2020
Embo Molecular Medicine
Bai-Liang He
Ning Yang
Cheuk Him Man
Nelson K. L. Ng
Chae-Yin Cher
Ho Ching Leung
Leo Lai Hok Kan
Bowie Yik Ling Cheng
Stephen S. Y. Lam
Michelle Lu Lu Wang
Chun Xiao Zhang
H Kwok
Grace Cheng
R. Sharma
Alvin C.H. Ma
Chi Wai Eric So
Yok-Lam Kwong
Anskar Y. H. Leung
Show All
Source
Cite
Save
Citations (0)
1